← Back to Search

Stent

Wingspan Stent System for Stroke (WEAVE Trial)

N/A
Waitlist Available
Led By Michael J Alexander, M.D.
Research Sponsored by Stryker Neurovascular
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients for whom treatment with the Wingspan Stent System is considered
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 90 days post procedure
Awards & highlights
No Placebo-Only Group

Summary

The primary objective of this study is to evaluate the rate of stroke and/or death in patients treated with the Wingspan Stent System, according to the Indications for Use, within 72 hours post procedure.

Eligible Conditions
  • Stroke

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 90 days post procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 90 days post procedure for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of Stroke or Death Among Participants
Secondary study objectives
Rate of Ischemic Stroke Among Participants
Rate of Neurological Death Among Participants
Rate of Stroke Recovery Among Participants
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Wingspan Stent SystemExperimental Treatment1 Intervention
Placement of the Wingspan Stent
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Wingspan Stent System
2013
N/A
~160

Find a Location

Who is running the clinical trial?

Stryker NeurovascularLead Sponsor
35 Previous Clinical Trials
12,591 Total Patients Enrolled
11 Trials studying Stroke
4,082 Patients Enrolled for Stroke
Michael J Alexander, M.D.Principal InvestigatorCedars-Sinai Medical Center
Wengui Yu, M.D.Principal InvestigatorUniversity of California, Irvine
~13 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top